MST1 interactomes profiling across cell death in esophageal squamous cell carcinoma
Author:
Zhang Li1, Gao Mingwei2, Wu Yueguang1, Liu Huijuan3, Zhuang Xuehan1, Zhou Yan3, Song Qiqin1, Bi Shanshan1, Zhang Weimin1, Cui Yongping1ORCID
Affiliation:
1. 610537 Cancer Institute, Shenzhen-Peking University-the Hong Kong University of Science and Technology Medical Center , Shenzhen , Guangdong , China 2. 74573 Department of Oncology, Peking University Shenzhen Hospital , Shenzhen , Guangdong , China 3. 551667 Institute of Cancer Research, Shenzhen Bay Laboratory , Shenzhen , Guangdong , China
Abstract
Abstract
Objectives
Resistance to apoptosis in esophageal squamous cell carcinoma (ESCC) constitutes a significant impediment to treatment efficacy. Exploring alternative cell death pathways and their regulatory factors beyond apoptosis is crucial for overcoming drug resistance and enhancing therapeutic outcomes in ESCC.
Methods
Mammalian Ste 20-like kinase 1 (MST1) is implicated in regulating various cell deaths, including apoptosis, autophagy, and pyroptosis. Employing enhanced ascorbate peroxidase 2 (APEX2) proximity labeling coupled with immunoprecipitation-mass spectrometry (IP-MS), we elucidated the interactomes of MST1 across these three cell death paradigms.
Results
Proteomic profiling unveiled the functional roles and subcellular localization of MST1 and its interacting proteins during normal proliferation and various cell death processes. Notably, MST1 exhibited an expanded interactome during cell death compared to normal proliferation and chromosome remodeling functions consistently. In apoptosis, there was a notable increase of mitosis-associated proteins such as INCENP, ANLN, KIF23, SHCBP1 and SUPT16H, which interacted with MST1, alongside decreased expression of the pre-apoptotic protein STK3. During autophagy, the bindings of DNA repair-related proteins CBX8 and m6A reader YTHDC1 to MST1 were enhanced. In pyroptosis, LRRFIP2 and FLII which can inhibit pyroptosis increasingly binding to MST1.
Conclusions
Our findings delineate potential mechanisms through which MST1 and its interactomes regulate cell death, paving the way for further investigation to validate and consolidate these observations.
Funder
Shenzhen 'San-Ming' Project of Medicine China Postdoctoral Science Foundation National Key Research and Development Program of China Guangdong Basic and Applied Basic Research Foundation Shenzhen Medical Research Funds Major Program of Shenzhen Bay Laboratory National Natural Science Foundation of China
Publisher
Walter de Gruyter GmbH
Reference50 articles.
1. Abnet, CC, Arnold, M, Wei, WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018;154:360–73. https://doi.org/10.1053/j.gastro.2017.08.023. 2. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660. 3. Cui, J, Zhou, Z, Yang, H, Jiao, F, Li, N, Gao, Y, et al.. MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis. Mol Cancer Res 2019;17:1316–25. https://doi.org/10.1158/1541-7786.mcr-18-0910. 4. Wilkinson, DS, Jariwala, JS, Anderson, E, Mitra, K, Meisenhelder, J, Chang, JT, et al.. Phosphorylation of LC3 by the Hippo kinases STK3/STK4 is essential for autophagy. Mol Cell 2015;57:55–68. https://doi.org/10.1016/j.molcel.2014.11.019. 5. Rawat, SJ, Chernoff, J. Regulation of mammalian Ste20 (Mst) kinases. Trends Biochem Sci 2015;40:149–56. https://doi.org/10.1016/j.tibs.2015.01.001.
|
|